{ "entity_id": "B-002559", "folder": "Australian-Health-Protection-Principal-Committee", "name": "Australian Health Protection Principal Committee", "type": "Ministerial Council", "jurisdiction": "Commonwealth", "portfolio": "Health, Disability and Ageing", "website": "https://www.health.gov.au/committees-and-groups/australian-health-protection-principal-committee-ahppc", "data_status": "stub", "completeness": { "has_strategy_brief": false, "has_strategy_structured": true, "has_vision": false, "has_kpi_targets": false, "has_kpi_results": false, "has_strategy_overview": true, "has_legislation_text": true, "has_legislation_structured": false, "has_global_initiatives_text": false, "has_ideas": true, "has_artifacts": true, "n_ideas": 12, "n_legislation": 0, "n_artifacts": 1, "n_kpi_targets": 0, "n_kpi_results": 0, "n_outcomes": 0, "verified_own_data": true }, "strategy_profile": { "status": "needs_review", "confidence": "medium", "summary": "", "official_site_url": "https://www.health.gov.au/committees-and-groups/australian-health-protection-principal-committee-ahppc", "source_documents": [], "purpose": null, "vision": null, "strategic_priorities": [], "values": [], "outcomes": [], "performance_measures": [], "document_alignment_terms": { "must_support": [], "watch_terms": [], "avoid_claiming_without_evidence": [] }, "review_note": "Structured strategy exists but is incomplete." }, "strategy_brief_md": null, "strategy_overview_evidence_md": null, "internal_strategy_evidence_md": "# Australian Health Protection Principal Committee - Strategy, Performance, and Operating Profile\n\n**Generated at**: 2026-05-09T22:18:40.787558+00:00\n**Entity ID**: B-002559\n**Entity type**: Ministerial Council\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n**Website**: https://www.health.gov.au/committees-and-groups/australian-health-protection-principal-committee-ahppc\n\n> Draft generated from scraped source material. Treat this as an evidence pack for editorial review, not a final judgement.\n\n## Source Coverage\n\n| Source type | Count |\n|---|---:|\n| other-pdfs | 1 |\n| pages | 35 |\n\n## Executive Readout\n\n### Purpose\n\n- Filter results\nYou can narrow down the results using the filters\nType\nCampaign\n(30)\nInitiative\n(303)\nProgram\n(85)\nReform\n(13)\nReview\n(25)\nAudience\nGeneral public\n(366)\nHealthcare workers\n(7)\nHealth professionals\n(76)\nIndustry\n(18)\nProviders\n(39)\nStudents and trainees\n(17)\nTopics\nAboriginal and Torres Strait Islander health\n(30)\nAboriginal and Torres Strait Islander health workforce\n(12)\nAbout the department\n(2)\nAged care\n(78)\nAged care workforce\n(15)\nAlcohol\n(3)\nAllied health care\n(17)\nBladder and bowel\n(4)\nBlood and blood products\n(2)\nCancer\n(16)\nChildren's health\n(14)\nChronic conditions\n(17)\nCommunicable diseases\n(6)\nDementia\n(12)\nDental health\n(1)\nDentists and dental practitioners\n(3)\nDisability and carers\n(35)\nDrugs\n(4)\nEar health and hearing\n(5)\nEmergency health management\n(5)\nEye health and vision\n(2)\nFamily, domestic and sexual violence\n(4)\nFood and nutrition\n(5)\nGeneral practice\n Source: `pages/priorities-index.html (https://www.health.gov.au/our-work)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- General statements\n15 December 2025\n– Statement of support\n12 December 2025\n– Increased influenza activity and guidance for the holiday season\n28 July 2025\n– Not too late to vaccinate\n30 May 2025\n– Statement on measles\n6 January 2025\n– Statement of Appreciation for Professor Paul Kelly\n10 May 2024\n– Statement on e-cigarettes\nCoronavirus (COVID-19)\n20 October\n– End of COVID-19 emergency response\n25 August 2023\n– Advice to support safe cruising\n8 September 2022\n– Statement on reduced isolation period for COVID-19 cases\n8 July 2022\n– Statement on COVID-19 winter update and ongoing health protection measures to support our community\n14 June 2022\n– Statement on the Removal of Mask Mandates in Airports\n23 May 2022\n– Statement on national principles for modified quarantine\n31 March 2022\n– Statement on winter season preparedness\n20 January 2022\n Source: `pages/announcements-index.html (https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements)`\n\n### Role and Functions\n\n- General statements\n15 December 2025\n– Statement of support\n12 December 2025\n– Increased influenza activity and guidance for the holiday season\n28 July 2025\n– Not too late to vaccinate\n30 May 2025\n– Statement on measles\n6 January 2025\n– Statement of Appreciation for Professor Paul Kelly\n10 May 2024\n– Statement on e-cigarettes\nCoronavirus (COVID-19)\n20 October\n– End of COVID-19 emergency response\n25 August 2023\n– Advice to support safe cruising\n8 September 2022\n– Statement on reduced isolation period for COVID-19 cases\n8 July 2022\n– Statement on COVID-19 winter update and ongoing health protection measures to support our community\n14 June 2022\n– Statement on the Removal of Mask Mandates in Airports\n23 May 2022\n– Statement on national principles for modified quarantine\n31 March 2022\n– Statement on winter season preparedness\n20 January 2022\n Source: `pages/announcements-index.html (https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- There are a range of health behaviours all Australians can undertake to reduce the transmission of COVID-19, protect the community, in particular those most at risk, and protect our health system and essential services, such as:\nStaying up to date with your vaccinations\nThe Australian Technical Advisory Group on Immunisation recommends that adults aged 50 to 64 years receive a winter booster dose of a COVID-19 vaccine\nAdults aged 30 to 49 years can also now receive a winter booster dose\nMore information can be found at\nATAGI updated recommendations for a winter dose of COVID-19 vaccine\nWearing a mask outside your home when in crowded, indoor environments including on public transport.\n Source: `pages/announcements-index__13.html (https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community)`\n- All accommodation providers and staff (e.g. cleaners, receptionists and building managers) in these facilities should have an adequate understanding of their role and responsibilities in relation to IPC practices, behaviours, and reporting requirements, if concerns are identified.\n Source: `pages/announcements-index__15.html (https://www.health.gov.au/news/committee-statements/national-principles-for-modified-quarantine)`\n- Inspired by the growing body of scientific evidence that face masks can slow the spread of the\ndisease and save lives [1, 2, 3, 4, 5, 6, 7, 8], we conducted a cluster-randomized controlled trial\ncovering 342,126 adults in 600 villages in rural Bangladesh with the dual goals of (a) identifying\nstrategies to encourage community-wide mask-wearing, and (b) tracking changes in symptomatic\nSARS-CoV-2 infections as a result of our intervention.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n\n### Strategic Priorities\n\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- General statements\n15 December 2025\n– Statement of support\n12 December 2025\n– Increased influenza activity and guidance for the holiday season\n28 July 2025\n– Not too late to vaccinate\n30 May 2025\n– Statement on measles\n6 January 2025\n– Statement of Appreciation for Professor Paul Kelly\n10 May 2024\n– Statement on e-cigarettes\nCoronavirus (COVID-19)\n20 October\n– End of COVID-19 emergency response\n25 August 2023\n– Advice to support safe cruising\n8 September 2022\n– Statement on reduced isolation period for COVID-19 cases\n8 July 2022\n– Statement on COVID-19 winter update and ongoing health protection measures to support our community\n14 June 2022\n– Statement on the Removal of Mask Mandates in Airports\n23 May 2022\n– Statement on national principles for modified quarantine\n31 March 2022\n– Statement on winter season preparedness\n20 January 2022\n Source: `pages/announcements-index.html (https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements)`\n- AHPC emphasises 4 priority areas:\nOn-time vaccination for children-\nThe\nNational Immunisation Program (NIP) Schedule\nrecommends children receive MMR (measles–mumps–rubella) vaccination at 12 months and MMRV (measles–mumps–rubella–varicella) vaccination at 18 months.\n Source: `pages/announcements-index__07.html (https://www.health.gov.au/news/ahpc-statement-on-measles)`\n- There are a range of health behaviours all Australians can undertake to reduce the transmission of COVID-19, protect the community, in particular those most at risk, and protect our health system and essential services, such as:\nStaying up to date with your vaccinations\nThe Australian Technical Advisory Group on Immunisation recommends that adults aged 50 to 64 years receive a winter booster dose of a COVID-19 vaccine\nAdults aged 30 to 49 years can also now receive a winter booster dose\nMore information can be found at\nATAGI updated recommendations for a winter dose of COVID-19 vaccine\nWearing a mask outside your home when in crowded, indoor environments including on public transport.\n Source: `pages/announcements-index__13.html (https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community)`\n- Inspired by the growing body of scientific evidence that face masks can slow the spread of the\ndisease and save lives [1, 2, 3, 4, 5, 6, 7, 8], we conducted a cluster-randomized controlled trial\ncovering 342,126 adults in 600 villages in rural Bangladesh with the dual goals of (a) identifying\nstrategies to encourage community-wide mask-wearing, and (b) tracking changes in symptomatic\nSARS-CoV-2 infections as a result of our intervention.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- The same staff member conducted surveillance at paired intervention and control villages at\nbaseline and then once per week on weeks 1, 2, 4, 6, 8, and 10 after the intervention.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Table A15 synthesizes these results, collapsing by categories\nof <40, 40-50, 50-60 and 60+, and Table A16 reports the same results as a relative risk reduction,\nseparately for cloth and surgical masks.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Okoffo, The Science of the total environment 737, 140279 (2020).\n[33] Environment and Social Development Organization (EDSO) (Bangladesh), Covid-19 pan-\ndemic pushes single use plastic waste outbreak: No management, no protection: High health\nand environmental risk unveil (2020).\n[34] I.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Costs per village The main fixed costs of the intervention (as opposed to costs that vary over\ndays):\n• Masks for initial household distribution (3 masks per household), ($0.13 per surgical mask\nand $0.50 per cloth masks), 68,775 cloth masks, and 136,770 surgical masks\n• Staffing for initial household distribution (4 person-days per village)\n• 1 person-day of training per village\n• PPE for staff: $70 per village\n• Media costs: $100 per village\n• Other transportation and materials costs: $30 per village\nThis amounts to fixed costs of: $302.50 per village for non-mask materials, $347.35 worth of cloth\nmasks per village, and $89.35 of surgical masks per village.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n\n## KPIs, Targets, and Where They Are At\n\n- Inspired by the growing body of scientific evidence that face masks can slow the spread of the\ndisease and save lives [1, 2, 3, 4, 5, 6, 7, 8], we conducted a cluster-randomized controlled trial\ncovering 342,126 adults in 600 villages in rural Bangladesh with the dual goals of (a) identifying\nstrategies to encourage community-wide mask-wearing, and (b) tracking changes in symptomatic\nSARS-CoV-2 infections as a result of our intervention.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- General statements\n15 December 2025\n– Statement of support\n12 December 2025\n– Increased influenza activity and guidance for the holiday season\n28 July 2025\n– Not too late to vaccinate\n30 May 2025\n– Statement on measles\n6 January 2025\n– Statement of Appreciation for Professor Paul Kelly\n10 May 2024\n– Statement on e-cigarettes\nCoronavirus (COVID-19)\n20 October\n– End of COVID-19 emergency response\n25 August 2023\n– Advice to support safe cruising\n8 September 2022\n– Statement on reduced isolation period for COVID-19 cases\n8 July 2022\n– Statement on COVID-19 winter update and ongoing health protection measures to support our community\n14 June 2022\n– Statement on the Removal of Mask Mandates in Airports\n23 May 2022\n– Statement on national principles for modified quarantine\n31 March 2022\n– Statement on winter season preparedness\n20 January 2022\n Source: `pages/announcements-index.html (https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements)`\n- There are a range of health behaviours all Australians can undertake to reduce the transmission of COVID-19, protect the community, in particular those most at risk, and protect our health system and essential services, such as:\nStaying up to date with your vaccinations\nThe Australian Technical Advisory Group on Immunisation recommends that adults aged 50 to 64 years receive a winter booster dose of a COVID-19 vaccine\nAdults aged 30 to 49 years can also now receive a winter booster dose\nMore information can be found at\nATAGI updated recommendations for a winter dose of COVID-19 vaccine\nWearing a mask outside your home when in crowded, indoor environments including on public transport.\n Source: `pages/announcements-index__13.html (https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community)`\n- Ensuring indoor spaces are well ventilated\nStaying home if you have any COVID-19 symptoms, no matter how mild, and get tested\nIf you have any symptoms, are at higher risk of severe illness and have a negative Rapid Antigen Test (RAT) result, seek a PCR test to confirm whether or not you have COVID-19 so you can access oral treatments for COVID-19 if eligible.\n Source: `pages/announcements-index__13.html (https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community)`\n- In addition, whilst not a target group for COVID-19 vaccine, the provision of influenza vaccination for the 6 month to 5 year age group needs particular attention after two years of minimal influenza transmission in Australia.\n Source: `pages/announcements-index__16.html (https://www.health.gov.au/news/ahppc-statement-on-winter-season-preparedness)`\n- The same staff member conducted surveillance at paired intervention and control villages at\nbaseline and then once per week on weeks 1, 2, 4, 6, 8, and 10 after the intervention.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Table A15 synthesizes these results, collapsing by categories\nof <40, 40-50, 50-60 and 60+, and Table A16 reports the same results as a relative risk reduction,\nseparately for cloth and surgical masks.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Okoffo, The Science of the total environment 737, 140279 (2020).\n[33] Environment and Social Development Organization (EDSO) (Bangladesh), Covid-19 pan-\ndemic pushes single use plastic waste outbreak: No management, no protection: High health\nand environmental risk unveil (2020).\n[34] I.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Costs per village The main fixed costs of the intervention (as opposed to costs that vary over\ndays):\n• Masks for initial household distribution (3 masks per household), ($0.13 per surgical mask\nand $0.50 per cloth masks), 68,775 cloth masks, and 136,770 surgical masks\n• Staffing for initial household distribution (4 person-days per village)\n• 1 person-day of training per village\n• PPE for staff: $70 per village\n• Media costs: $100 per village\n• Other transportation and materials costs: $30 per village\nThis amounts to fixed costs of: $302.50 per village for non-mask materials, $347.35 worth of cloth\nmasks per village, and $89.35 of surgical masks per village.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Table S7: Calculation of Number Needed to Treat and Cost per Life Saved\nCOVID-19- Estimated ARR NNT Cost per Cost per\nrelated Deaths with Life Saved - Life Saved -\nDeaths Intervention† Intervention at Scale\n(May 1 - Sept (USD) (USD)\n1, 2021)*\nLower bound 17,984 13,233 2.86E-05 35,001 $332,161 $52,502\nMid-range 56,097 41,276 8.91E-05 11,221 $106,487 $16,831\nUpper bound 94,209 69,319 1.50E-04 6,682 $63,408 $10,022\nARR = Absolute Risk Reduction; NNT = Number Needed to Treat\n*https://covid19.healthdata.org/bangladesh\n†Applying 35% reduction to deaths in the 60+ age group and 23% reduction to deaths in the 50-59 age group\nMany cost elements can be brought down further through \"at-scale implementation\".\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- 1 – Using RAT as a diagnostic test as an alternative to PCR for those at high risk of having COVID-19\nCohort\nTesting Recommendation\nComment\nPeople residing in the household with a known COVID-19 case\nRAT on notification and Day 6\nAdditional RAT if symptomatic\nPositive RAT should be considered confirmed COVID-19 case regardless of symptoms.\n Source: `pages/announcements-index__17.html (https://www.health.gov.au/news/ahppc-statement-on-rapid-antigen-testing-for-current-high-community-prevalence-environment)`\n- We assume that (1) all reported symptoms were acute onset, (2) all people live or work in an area with high risk of\ntransmission of virus and (3) all people have been a contact of a probable or confirmed case of COVID-19 or are\nlinked to a COVID-19 cluster.\n“Other Locations” include tea stalls, at the entrance of the restaurant as patrons enter, and the main road to enter the\nvillage.\n“Surgical Villages” refer to all treatment villages which received surgical masks as part of the intervention, and their\ncontrol pairs. “Cloth Villages” refer to all treatment villages which received cloth masks as part of the intervention,\nand their control pairs.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n\n## Key Metrics\n\n| Values found | Evidence | Source |\n|---|---|---|\n| $0.13 , $0.50 , $70 , $100 , $30 , $302.50 | Costs per village The main fixed costs of the intervention (as opposed to costs that vary over\ndays):\n• Masks for initial household distribution (3 masks per household), ($0.13 per surgical mask\nand $0.50 per cloth masks), 68,775 cloth masks, and 136,770 surgical masks\n• Staffing for initial household distribution (4 person-days per village)\n• 1 person-day of training per village\n• PPE for staff: $70 per village\n• Media costs: $100 per village\n• | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $23 million, 23 million | Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n| $20 , $0.50 | [Page 88]\nI Intervention Cost and Benefit Estimates\nThe average person-day of staff time in our intervention cost $20 of wages plus $0.50 of communi-\ncation costs. | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $74 million, 74 million | Have your say on the aged care reforms\n23 March 2026\nNews\nThe Aged Care Reform Sector Pulse Survey is your opportunity to share your feedback about the implementation of the aged care reforms.\n$74 million to drive genomic health research\n19 March 2026\nNews\nRead about the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n| $332,161 , $52,502\nM, $106,487 , $16,831\n, $63,408 , $10,022 | Table S7: Calculation of Number Needed to Treat and Cost per Life Saved\nCOVID-19- Estimated ARR NNT Cost per Cost per\nrelated Deaths with Life Saved - Life Saved -\nDeaths Intervention† Intervention at Scale\n(May 1 - Sept (USD) (USD)\n1, 2021)*\nLower bound 17,984 13,233 2.86E-05 35,001 $332,161 $52,502\nMid-range 56,097 41,276 8.91E-05 11,221 $106,487 $16,831\nUpper bound 94,209 69,319 1.50E-04 6,682 $63,408 $10,022\nARR = Absolute Risk Reduction; NNT | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $205,000 | For context, [63] estimate that the value of a statistical life is $205,000 in Bangladesh, implying\nthat our intervention at scale is 4-20 times more cost-effective than what the typical Bangladeshi\nwould be willing to pay to reduce mortality risk, and therefore a \"very good buy\" for policymakers. | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $100 | Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission. | `pages/about.html (https://www.health.gov.au/topics/about-the-department)` |\n| $0.50 , $0.13 , $0.06 | [Page 10]\nmask prices of $0.50 per cloth mask and $0.13 per surgical mask ($0.06 of which was the cost of a\nsticker reminding people they could wash and reuse the surgical mask). | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $205,000, , $9,200 | This is considerably lower than the value of a statistical life in Bangladesh\n($205,000, [63]) and under severe outbreaks, is comparable to the most cost-efficient humanitarian\nprograms at scale (e.g. distributing insecticide nets to prevent malaria costs $9,200 per life saved\n[64]). | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $3.75 , $2.26 | We estimate that we induced 598\nx 29% = 173 people per village to wear masks, which amounts to fixed costs of $3.75 per adult\ninduced to wear a mask in cloth mask villages, and $2.26 per adult in surgical mask villages. | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $30 , $302.50 , $347.35 , $89.35 | [pages 88,89,90,91,92]\ner village\n• Other transportation and materials costs: $30 per village\nThis amounts to fixed costs of: $302.50 per village for non-mask materials, $347.35 worth of cloth\nmasks per village, and $89.35 of surgical masks per village. | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $3.75 , $0.44 , $17.00 | Our estimates above suggest that the total cost of our\nintervention per person induced to wear a mask for a month was: $3.75 + $0.44 x 30 = $17.00\n89 | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $2.26 , $0.24 , $9.49 | [Page 90]\nin cloth mask villages and $2.26 + $0.24 x 30 = $9.49 in surgical mask villages. | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $0.13 , $0.50 , $70 , $100 , $30 , $302.50 | Costs per village The main fixed costs of the intervention (as opposed to costs that vary over\ndays):\n• Masks for initial household distribution (3 masks per household), ($0.13 per surgical mask\nand $0.50 per cloth masks), 68,775 cloth masks, and 136,770 surgical masks\n• Staffing for initial household distribution (4 person-days per village)\n• 1 person-day of training per village\n• PPE for staff: $70 per village\n• Media costs: $100 per village\n• | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $332,161 , $52,502\nM, $106,487 , $16,831\n, $63,408 , $10,022 | Table S7: Calculation of Number Needed to Treat and Cost per Life Saved\nCOVID-19- Estimated ARR NNT Cost per Cost per\nrelated Deaths with Life Saved - Life Saved -\nDeaths Intervention† Intervention at Scale\n(May 1 - Sept (USD) (USD)\n1, 2021)*\nLower bound 17,984 13,233 2.86E-05 35,001 $332,161 $52,502\nMid-range 56,097 41,276 8.91E-05 11,221 $106,487 $16,831\nUpper bound 94,209 69,319 1.50E-04 6,682 $63,408 $10,022\nARR = Absolute Risk Reduction; NNT | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $205,000 | For context, [63] estimate that the value of a statistical life is $205,000 in Bangladesh, implying\nthat our intervention at scale is 4-20 times more cost-effective than what the typical Bangladeshi\nwould be willing to pay to reduce mortality risk, and therefore a \"very good buy\" for policymakers. | `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)` |\n| $100 | Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission. | `pages/about.html (https://www.health.gov.au/topics/about-the-department)` |\n\n## Key Achievements\n\n- 3.7 Piloting Interventions\nIPA implemented two pilots: Pilot 1 from July 22-31 and Pilot 2 from August 13-26, 2020.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- General statements\n15 December 2025\n– Statement of support\n12 December 2025\n– Increased influenza activity and guidance for the holiday season\n28 July 2025\n– Not too late to vaccinate\n30 May 2025\n– Statement on measles\n6 January 2025\n– Statement of Appreciation for Professor Paul Kelly\n10 May 2024\n– Statement on e-cigarettes\nCoronavirus (COVID-19)\n20 October\n– End of COVID-19 emergency response\n25 August 2023\n– Advice to support safe cruising\n8 September 2022\n– Statement on reduced isolation period for COVID-19 cases\n8 July 2022\n– Statement on COVID-19 winter update and ongoing health protection measures to support our community\n14 June 2022\n– Statement on the Removal of Mask Mandates in Airports\n23 May 2022\n– Statement on national principles for modified quarantine\n31 March 2022\n– Statement on winter season preparedness\n20 January 2022\n Source: `pages/announcements-index.html (https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements)`\n- There are a range of health behaviours all Australians can undertake to reduce the transmission of COVID-19, protect the community, in particular those most at risk, and protect our health system and essential services, such as:\nStaying up to date with your vaccinations\nThe Australian Technical Advisory Group on Immunisation recommends that adults aged 50 to 64 years receive a winter booster dose of a COVID-19 vaccine\nAdults aged 30 to 49 years can also now receive a winter booster dose\nMore information can be found at\nATAGI updated recommendations for a winter dose of COVID-19 vaccine\nWearing a mask outside your home when in crowded, indoor environments including on public transport.\n Source: `pages/announcements-index__13.html (https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community)`\n- Inspired by the growing body of scientific evidence that face masks can slow the spread of the\ndisease and save lives [1, 2, 3, 4, 5, 6, 7, 8], we conducted a cluster-randomized controlled trial\ncovering 342,126 adults in 600 villages in rural Bangladesh with the dual goals of (a) identifying\nstrategies to encourage community-wide mask-wearing, and (b) tracking changes in symptomatic\nSARS-CoV-2 infections as a result of our intervention.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- The same staff member conducted surveillance at paired intervention and control villages at\nbaseline and then once per week on weeks 1, 2, 4, 6, 8, and 10 after the intervention.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Symptomatic Seroprevalence Among the 335,382 participants who completed symptom sur-\nveys, 27,166 (8.1%) reported experiencing COVID-like illnesses during the study period.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Table A15 synthesizes these results, collapsing by categories\nof <40, 40-50, 50-60 and 60+, and Table A16 reports the same results as a relative risk reduction,\nseparately for cloth and surgical masks.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Okoffo, The Science of the total environment 737, 140279 (2020).\n[33] Environment and Social Development Organization (EDSO) (Bangladesh), Covid-19 pan-\ndemic pushes single use plastic waste outbreak: No management, no protection: High health\nand environmental risk unveil (2020).\n[34] I.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Costs per village The main fixed costs of the intervention (as opposed to costs that vary over\ndays):\n• Masks for initial household distribution (3 masks per household), ($0.13 per surgical mask\nand $0.50 per cloth masks), 68,775 cloth masks, and 136,770 surgical masks\n• Staffing for initial household distribution (4 person-days per village)\n• 1 person-day of training per village\n• PPE for staff: $70 per village\n• Media costs: $100 per village\n• Other transportation and materials costs: $30 per village\nThis amounts to fixed costs of: $302.50 per village for non-mask materials, $347.35 worth of cloth\nmasks per village, and $89.35 of surgical masks per village.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Table S7: Calculation of Number Needed to Treat and Cost per Life Saved\nCOVID-19- Estimated ARR NNT Cost per Cost per\nrelated Deaths with Life Saved - Life Saved -\nDeaths Intervention† Intervention at Scale\n(May 1 - Sept (USD) (USD)\n1, 2021)*\nLower bound 17,984 13,233 2.86E-05 35,001 $332,161 $52,502\nMid-range 56,097 41,276 8.91E-05 11,221 $106,487 $16,831\nUpper bound 94,209 69,319 1.50E-04 6,682 $63,408 $10,022\nARR = Absolute Risk Reduction; NNT = Number Needed to Treat\n*https://covid19.healthdata.org/bangladesh\n†Applying 35% reduction to deaths in the 60+ age group and 23% reduction to deaths in the 50-59 age group\nMany cost elements can be brought down further through \"at-scale implementation\".\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n\n## Key Issues, Risks, and Recommendations\n\n- General statements\n15 December 2025\n– Statement of support\n12 December 2025\n– Increased influenza activity and guidance for the holiday season\n28 July 2025\n– Not too late to vaccinate\n30 May 2025\n– Statement on measles\n6 January 2025\n– Statement of Appreciation for Professor Paul Kelly\n10 May 2024\n– Statement on e-cigarettes\nCoronavirus (COVID-19)\n20 October\n– End of COVID-19 emergency response\n25 August 2023\n– Advice to support safe cruising\n8 September 2022\n– Statement on reduced isolation period for COVID-19 cases\n8 July 2022\n– Statement on COVID-19 winter update and ongoing health protection measures to support our community\n14 June 2022\n– Statement on the Removal of Mask Mandates in Airports\n23 May 2022\n– Statement on national principles for modified quarantine\n31 March 2022\n– Statement on winter season preparedness\n20 January 2022\n Source: `pages/announcements-index.html (https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements)`\n- There are a range of health behaviours all Australians can undertake to reduce the transmission of COVID-19, protect the community, in particular those most at risk, and protect our health system and essential services, such as:\nStaying up to date with your vaccinations\nThe Australian Technical Advisory Group on Immunisation recommends that adults aged 50 to 64 years receive a winter booster dose of a COVID-19 vaccine\nAdults aged 30 to 49 years can also now receive a winter booster dose\nMore information can be found at\nATAGI updated recommendations for a winter dose of COVID-19 vaccine\nWearing a mask outside your home when in crowded, indoor environments including on public transport.\n Source: `pages/announcements-index__13.html (https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community)`\n- 1 – Using RAT as a diagnostic test as an alternative to PCR for those at high risk of having COVID-19\nCohort\nTesting Recommendation\nComment\nPeople residing in the household with a known COVID-19 case\nRAT on notification and Day 6\nAdditional RAT if symptomatic\nPositive RAT should be considered confirmed COVID-19 case regardless of symptoms.\n Source: `pages/announcements-index__17.html (https://www.health.gov.au/news/ahppc-statement-on-rapid-antigen-testing-for-current-high-community-prevalence-environment)`\n- 3 – Using RAT to detect cases early in high-risk settings\nCohort\nTesting Recommendation\nComment\nResidential aged and disability care settings where there is high community prevalence\nDaily RAT for all staff (minimum twice weekly where supply constraints exist)\nRAT for visitors at each visit\nThis regime is subject to local consideration of community prevalence and availability of RAT.\n Source: `pages/announcements-index__17.html (https://www.health.gov.au/news/ahppc-statement-on-rapid-antigen-testing-for-current-high-community-prevalence-environment)`\n- Some people with disability are at greater risk from COVID-19 due to:\nchronic conditions or weak immune states placing them at greater risk of serious infection\nchallenges they face implementing COVID-19 safe behaviours (e.g. wearing masks, washing hands)\nreliance on close-proximity support from family, carers and support workers, and\nresiding in settings with greater risk of COVID-19 transmission e.g. group homes or larger residential care facilities.\n Source: `pages/announcements-index__26.html (https://www.health.gov.au/resources/committee-statements/mandating-booster-vaccination-for-disability-support-workers)`\n- Table A15 synthesizes these results, collapsing by categories\nof <40, 40-50, 50-60 and 60+, and Table A16 reports the same results as a relative risk reduction,\nseparately for cloth and surgical masks.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Okoffo, The Science of the total environment 737, 140279 (2020).\n[33] Environment and Social Development Organization (EDSO) (Bangladesh), Covid-19 pan-\ndemic pushes single use plastic waste outbreak: No management, no protection: High health\nand environmental risk unveil (2020).\n[34] I.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Table S7: Calculation of Number Needed to Treat and Cost per Life Saved\nCOVID-19- Estimated ARR NNT Cost per Cost per\nrelated Deaths with Life Saved - Life Saved -\nDeaths Intervention† Intervention at Scale\n(May 1 - Sept (USD) (USD)\n1, 2021)*\nLower bound 17,984 13,233 2.86E-05 35,001 $332,161 $52,502\nMid-range 56,097 41,276 8.91E-05 11,221 $106,487 $16,831\nUpper bound 94,209 69,319 1.50E-04 6,682 $63,408 $10,022\nARR = Absolute Risk Reduction; NNT = Number Needed to Treat\n*https://covid19.healthdata.org/bangladesh\n†Applying 35% reduction to deaths in the 60+ age group and 23% reduction to deaths in the 50-59 age group\nMany cost elements can be brought down further through \"at-scale implementation\".\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- We assume that (1) all reported symptoms were acute onset, (2) all people live or work in an area with high risk of\ntransmission of virus and (3) all people have been a contact of a probable or confirmed case of COVID-19 or are\nlinked to a COVID-19 cluster.\n“Other Locations” include tea stalls, at the entrance of the restaurant as patrons enter, and the main road to enter the\nvillage.\n“Surgical Villages” refer to all treatment villages which received surgical masks as part of the intervention, and their\ncontrol pairs. “Cloth Villages” refer to all treatment villages which received cloth masks as part of the intervention,\nand their control pairs.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Additionally, the intervention reduced symptomatic\nseroprevalence more when surgical masks were used, and even more for the highest-risk individu-\nals in our sample (23% for ages 50-60 and 35% for ages 60+).\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- For context, [63] estimate that the value of a statistical life is $205,000 in Bangladesh, implying\nthat our intervention at scale is 4-20 times more cost-effective than what the typical Bangladeshi\nwould be willing to pay to reduce mortality risk, and therefore a \"very good buy\" for policymakers.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- AHPPC notes\nthe demands for the hospital system in managing the multiple challenges of the existing COVID-19 case load, the usual care of acute medical and surgical activities, the backlog of elective surgery and health issues due to delayed health care, along with the greater burden on staff due to enhanced infection prevention and control measures.\n Source: `pages/announcements-index__16.html (https://www.health.gov.au/news/ahppc-statement-on-winter-season-preparedness)`\n- AHPPC Statement - Mandating booster vaccination for disability support workers (16 March 2022)\nUpdated CDNA National Guidance for remote Aboriginal and Torres Strait Islander communities for COVID-19 (16 February 2022)\nAHPPC interim guidance - Permissions and Restrictions for Workers in Health Care Settings (10 January 2022)\nAHPPC Statement - Mandating booster vaccination for residential aged care workers (15 February 2022)\nUpdated CDNA National Guidelines for the Prevention, Control and Public Health Management of COVID-19 Outbreaks in Residential Aged Care Facilities (15 February 2022)\nAHPPC interim guidance on permissions and restrictions for workers in food and grocery supply (10 January 2022)\nAHPPC statement on testing, tracing, isolating and quarantining in high-levels of COVID-19 community transmission (30 December 2021) that states:\nContacts exposed in non-household settings (e.\n Source: `pages/announcements-index__16.html (https://www.health.gov.au/news/ahppc-statement-on-winter-season-preparedness)`\n- 2 – Using RAT to manage outbreaks\nCohort\nTesting Recommendation\nComment\nHigh-risk settings (healthcare, aged care, disability care, correctional facilities)\nRAT testing to identify initial extent in the facility.\n Source: `pages/announcements-index__17.html (https://www.health.gov.au/news/ahppc-statement-on-rapid-antigen-testing-for-current-high-community-prevalence-environment)`\n\n## Corporate Values and Operating Culture\n\n- There are a range of health behaviours all Australians can undertake to reduce the transmission of COVID-19, protect the community, in particular those most at risk, and protect our health system and essential services, such as:\nStaying up to date with your vaccinations\nThe Australian Technical Advisory Group on Immunisation recommends that adults aged 50 to 64 years receive a winter booster dose of a COVID-19 vaccine\nAdults aged 30 to 49 years can also now receive a winter booster dose\nMore information can be found at\nATAGI updated recommendations for a winter dose of COVID-19 vaccine\nWearing a mask outside your home when in crowded, indoor environments including on public transport.\n Source: `pages/announcements-index__13.html (https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community)`\n- For context, [63] estimate that the value of a statistical life is $205,000 in Bangladesh, implying\nthat our intervention at scale is 4-20 times more cost-effective than what the typical Bangladeshi\nwould be willing to pay to reduce mortality risk, and therefore a \"very good buy\" for policymakers.\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.\n Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- Support is also available from:\nMedicare Mental Health phone service on 1800 595 212 or visit the Government’s\nMedicare Mental Health\nwebsite to find mental health services and resources\nLifeline\non 13 11 14, text 0477 13 11 14 or access its services online including chat\nKids Helpline\non 1800 55 1800 or access its services online\nBeyond Blue\non 1300 22 4636 or access its services online\nNurse Midwife Health Program Australia\n1800 001060\nDoctors' Health Line 1800 006 888\nthe Transcultural Mental Health Line on 1800 648 911\n13 YARN\n: 13 92 76 – Aboriginal and Torres Strait Islander Crisis Support\nDr4Drs\non 1300 374 377\nThe\nEssential Network (TEN) Black Dog Institute | Better Mental Health\n.\n Source: `pages/announcements-index__04.html (https://www.health.gov.au/news/statement-of-support)`\n- Filter results\nYou can narrow down the results using the filters\nType\nCampaign\n(30)\nInitiative\n(303)\nProgram\n(85)\nReform\n(13)\nReview\n(25)\nAudience\nGeneral public\n(366)\nHealthcare workers\n(7)\nHealth professionals\n(76)\nIndustry\n(18)\nProviders\n(39)\nStudents and trainees\n(17)\nTopics\nAboriginal and Torres Strait Islander health\n(30)\nAboriginal and Torres Strait Islander health workforce\n(12)\nAbout the department\n(2)\nAged care\n(78)\nAged care workforce\n(15)\nAlcohol\n(3)\nAllied health care\n(17)\nBladder and bowel\n(4)\nBlood and blood products\n(2)\nCancer\n(16)\nChildren's health\n(14)\nChronic conditions\n(17)\nCommunicable diseases\n(6)\nDementia\n(12)\nDental health\n(1)\nDentists and dental practitioners\n(3)\nDisability and carers\n(35)\nDrugs\n(4)\nEar health and hearing\n(5)\nEmergency health management\n(5)\nEye health and vision\n(2)\nFamily, domestic and sexual violence\n(4)\nFood and nutrition\n(5)\nGeneral practice\n Source: `pages/priorities-index.html (https://www.health.gov.au/our-work)`\n- Subscribe\nNews\nNews\nTraining and professional development opportunities for aged care workers\n11 March 2026\nAged Care Provider Workforce Survey\n9 February 2026\nEOI: Support at Home pooled funding trial workshops\n29 October 2025\nView more news\nResources\nPrinciple 3 - Access the Outdoors: National Aged Care Design and Guidelines Webinar Series: Home Matters - Rethinking Aged Care Design\n30 April 2026\nPresentation\nThis webinar is for people working in aged care and design.\n Source: `pages/priorities-index__01.html (https://www.health.gov.au/our-work/aged-care-reforms?language=en)`\n- We test whether soft commitment devices encourage targets to follow through with\nactual behaviour change [44, 45], whether public displays can promote social norms [23], whether\nan altruistic framing inspires people more or less than self-interest [46], whether social image con-\ncerns and signaling can lead to higher compliance [47, 18], and whether regular reminders are a\nuseful tool to ensure adoption [19].\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n- This is considerably lower than the value of a statistical life in Bangladesh\n($205,000, [63]) and under severe outbreaks, is comparable to the most cost-efficient humanitarian\nprograms at scale (e.g. distributing insecticide nets to prevent malaria costs $9,200 per life saved\n[64]).\n Source: `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)`\n\n## Global Ideas and Case Study Inputs\n\n_No global-intelligence source text found yet. Run `CLAUDE/global-ideas-scraper.py ` to populate case-study sources._\n\n## Source Artifacts Used\n\n- `pages/about.html` - pages - https://www.health.gov.au/topics/about-the-department\n- `pages/announcements-index.html` - pages - https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements\n- `pages/announcements-index__02.html` - pages - https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements\n- `pages/announcements-index__03.html` - pages - https://www.health.gov.au/committees-and-groups/australian-health-protection-committee-ahpc/statements?language=en\n- `pages/announcements-index__04.html` - pages - https://www.health.gov.au/news/statement-of-support\n- `pages/announcements-index__05.html` - pages - https://www.health.gov.au/news/ahpc-statement-increased-influenza-activity-and-guidance-for-the-holiday-season\n- `pages/announcements-index__06.html` - pages - https://www.health.gov.au/news/ahpc-statement-not-too-late-to-vaccinate\n- `pages/announcements-index__07.html` - pages - https://www.health.gov.au/news/ahpc-statement-on-measles\n- `pages/announcements-index__08.html` - pages - https://www.health.gov.au/news/ahpc-statement-appreciation-statement-for-professor-paul-kelly\n- `pages/announcements-index__09.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-e-cigarettes-10-may-2024\n- `pages/announcements-index__10.html` - pages - https://www.health.gov.au/news/ahppc-statement-end-of-covid-19-emergency-response\n- `pages/announcements-index__11.html` - pages - https://www.health.gov.au/news/ahppc-statement-advice-to-support-safe-cruising\n- `pages/announcements-index__12.html` - pages - https://www.health.gov.au/news/ahppc-statement-reduced-isolation-period-for-covid-19-cases\n- `pages/announcements-index__13.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community\n- `pages/announcements-index__14.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-the-removal-of-mask-mandates-in-airports\n- `pages/announcements-index__15.html` - pages - https://www.health.gov.au/news/committee-statements/national-principles-for-modified-quarantine\n- `pages/announcements-index__16.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-winter-season-preparedness\n- `pages/announcements-index__17.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-rapid-antigen-testing-for-current-high-community-prevalence-environment\n- `pages/announcements-index__18.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-testing-tracing-isolating-and-quarantining-in-high-levels-of-covid-19-community-transmission\n- `pages/announcements-index__19.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-national-principles-for-end-to-end-best-practice-managed-quarantine-arrangements-for-international-travellers\n- `pages/announcements-index__20.html` - pages - https://www.health.gov.au/news/ahppc-statement-on-the-role-of-face-masks-to-protect-individuals-and-the-community-from-covid-19\n- `pages/announcements-index__21.html` - pages - https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-statement-on-recommendations-for-managing-covid-19-health-risks\n- `pages/announcements-index__22.html` - pages - https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-statement-on-the-role-of-ventilation-in-reducing-the-risk-of-transmission-of-covid-19\n- `pages/announcements-index__23.html` - pages - https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-statement-on-very-high-risk-social-environments\n- `pages/announcements-index__24.html` - pages - https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-statement-on-the-infection-control-expert-group\n- `pages/announcements-index__25.html` - pages - https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-statement-on-tobacco-use-e-cigarette-use-and-covid-19\n- `pages/announcements-index__26.html` - pages - https://www.health.gov.au/resources/committee-statements/mandating-booster-vaccination-for-disability-support-workers\n- `pages/announcements-index__27.html` - pages - https://www.health.gov.au/resources/committee-statements/mandating-booster-vaccinations-in-residential-aged-care-workers\n- `pages/announcements-index__28.html` - pages - https://www.health.gov.au/resources/publications/ahppc-interim-guidance-on-permissions-and-restrictions-for-workers-in-food-and-grocery-supply\n- `pages/announcements-index__29.html` - pages - https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-statement-on-mandating-vaccination-for-disability-support-workers\n- `pages/homepage.html` - pages - https://www.health.gov.au/committees-and-groups/australian-health-protection-principal-committee-ahppc\n- `pages/ministers.html` - pages - https://www.health.gov.au/ministers\n- `pages/news-latest.html` - pages - https://www.health.gov.au/news\n- `pages/priorities-index.html` - pages - https://www.health.gov.au/our-work\n- `pages/priorities-index__01.html` - pages - https://www.health.gov.au/our-work/aged-care-reforms?language=en\n- `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf` - other-pdfs - https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf\n\n## Gaps To Fix\n\n- No corporate plan text source found.\n- No annual report text source found.\n- No global comparison/case-study sources found.", "legislation_md": "# Australian Health Protection Principal Committee - Acts and Legislation Discovery\n\n**Generated at**: 2026-05-09T21:09:07.345845+00:00\n**Entity ID**: B-002559\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n\n> This is an evidence-based discovery list from scraped department material. A mention does not always mean the department administers the legislation; high-confidence and official register links should be reviewed.\n\n## Summary\n\n- Source files scanned: 36\n- Unique legislation references found: 2\n\n| Type | Count |\n|---|---:|\n| Regulation | 1 |\n| Rules | 1 |\n\n## Legislation References\n\n### International Health Regulations 2005\n\n**Type**: Regulation\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=International+Health+Regulations+2005\n\n**Sources**:\n- `pages/announcements-index__10.html`\n\n**Evidence contexts**:\n- se | Australian Government Department of Health, Disability and Ageing\n\nDate published:\n20 October 2023\nAudience:\nGeneral public\nCurrent context of COVID-19\nOn 5 May 2023, the World Health Organization (WHO) Director-General announced the determination of the\nInternational Health Regulations 2005\n(IHR) Emergency Committee for COVID-19 that COVID-19 no longer constituted a public health emergency of international concern (PHEIC).\nThe WHO Director-General stated COVID-19 remained a serious threat to global health and, while countries should avoid compla\n Source: `pages/announcements-index__10.html`\n\n### NDIS (Provider Registration and Practice Standards) Rules 2018\n\n**Type**: Rules\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=NDIS+%28Provider+Registration+and+Practice+Standards%29+Rules+2018\n\n**Sources**:\n- `pages/announcements-index__29.html`\n\n**Evidence contexts**:\n- re that care is not the usual responsibility of the health system.\ntherapeutic supports to facilitate functional improvement aimed at adjustment, adaption, and building capacity for community participation.\nThese classes of support are defined under the NDIS (Provider Registration and Practice Standards) Rules 2018. In the NDIS these are classes which relate to registered providers of supports only.\nAHPPC recommends that mandatory vaccination apply for disability support workers that meet the definitions above regardless of the setting they work in or are entering.\nAHPP\n Source: `pages/announcements-index__29.html`\n\n## Files Scanned\n\n- `pages/about.html` (page)\n- `pages/announcements-index.html` (page)\n- `pages/announcements-index__02.html` (page)\n- `pages/announcements-index__03.html` (page)\n- `pages/announcements-index__04.html` (page)\n- `pages/announcements-index__05.html` (page)\n- `pages/announcements-index__06.html` (page)\n- `pages/announcements-index__07.html` (page)\n- `pages/announcements-index__08.html` (page)\n- `pages/announcements-index__09.html` (page)\n- `pages/announcements-index__10.html` (page)\n- `pages/announcements-index__11.html` (page)\n- `pages/announcements-index__12.html` (page)\n- `pages/announcements-index__13.html` (page)\n- `pages/announcements-index__14.html` (page)\n- `pages/announcements-index__15.html` (page)\n- `pages/announcements-index__16.html` (page)\n- `pages/announcements-index__17.html` (page)\n- `pages/announcements-index__18.html` (page)\n- `pages/announcements-index__19.html` (page)\n- `pages/announcements-index__20.html` (page)\n- `pages/announcements-index__21.html` (page)\n- `pages/announcements-index__22.html` (page)\n- `pages/announcements-index__23.html` (page)\n- `pages/announcements-index__24.html` (page)\n- `pages/announcements-index__25.html` (page)\n- `pages/announcements-index__26.html` (page)\n- `pages/announcements-index__27.html` (page)\n- `pages/announcements-index__28.html` (page)\n- `pages/announcements-index__29.html` (page)\n- `pages/homepage.html` (page)\n- `pages/ministers.html` (page)\n- `pages/news-latest.html` (page)\n- `pages/priorities-index.html` (page)\n- `pages/priorities-index__01.html` (page)\n- `other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pages.jsonl` (pdf_pages)", "global_initiatives_md": null, "strategy": { "reporting_period": "2024-25", "corporate_plan_period": "2025-26", "vision": null, "vision_source_page": null, "purposes": null, "purposes_source_page": null, "how_we_deliver": null, "how_we_deliver_source_page": null, "government_priorities": [], "outcomes": [], "values": [], "values_framework_name": null, "kpi_targets_2025_26": [], "kpi_results_2024_25": [], "_source_urls": { "annual_report_url": "", "corporate_plan_url": "" } }, "ideas": [ { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Risk & Assurance", "scale": "small", "title": "Recommendation tracker for audits, reviews, and inquiries", "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.", "quote": "Some people with disability are at greater risk from COVID-19 due to:\nchronic conditions or weak immune states placing them at greater risk of serious infection\nchallenges they face implementing COVID-19 safe behaviours (e.g. wearing masks, washing hands)\nreliance on close-proximity support from family, carers and support workers, and\nresiding in settings with greater risk of COVID-19 transmission e.g. group homes or larger residential care facilities.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "pages/announcements-index__26.html (https://www.health.gov.au/resources/committee-statements/mandating-booster-vaccination-for-disability-support-workers)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Risk & Assurance", "scale": "large", "title": "Integrated assurance and lessons-learned system", "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.", "quote": "Some people with disability are at greater risk from COVID-19 due to:\nchronic conditions or weak immune states placing them at greater risk of serious infection\nchallenges they face implementing COVID-19 safe behaviours (e.g. wearing masks, washing hands)\nreliance on close-proximity support from family, carers and support workers, and\nresiding in settings with greater risk of COVID-19 transmission e.g. group homes or larger residential care facilities.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "pages/announcements-index__26.html (https://www.health.gov.au/resources/committee-statements/mandating-booster-vaccination-for-disability-support-workers)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Data & Performance", "scale": "small", "title": "KPI evidence register with named owners", "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.", "quote": "Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "pages/about.html (https://www.health.gov.au/topics/about-the-department)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Data & Performance", "scale": "large", "title": "Outcome dashboard linking budget, delivery, and public impact", "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.", "quote": "Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "pages/about.html (https://www.health.gov.au/topics/about-the-department)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Staff Productivity", "scale": "small", "title": "Reusable briefing and summary assistant for internal documents", "idea": "Create controlled templates for summarising reports, submissions, minutes, and ministerial briefs.", "quote": "Costs per village The main fixed costs of the intervention (as opposed to costs that vary over\ndays):\n• Masks for initial household distribution (3 masks per household), ($0.13 per surgical mask\nand $0.50 per cloth masks), 68,775 cloth masks, and 136,770 surgical masks\n• Staffing for initial household distribution (4 person-days per village)\n• 1 person-day of training per village\n• PPE for staff: $70 per village\n• Media costs: $100 per village\n• Other transportation and materials costs: $30 per village\nThis amounts to fixed costs of: $302.50 per village for non-mask materials, $347.35 worth of cloth\nmasks per village, and $89.35 of surgical masks per village.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Staff Productivity", "scale": "large", "title": "Department-wide knowledge and briefing platform", "idea": "Build a secure knowledge platform that lets staff search, summarise, and cite approved departmental material.", "quote": "Costs per village The main fixed costs of the intervention (as opposed to costs that vary over\ndays):\n• Masks for initial household distribution (3 masks per household), ($0.13 per surgical mask\nand $0.50 per cloth masks), 68,775 cloth masks, and 136,770 surgical masks\n• Staffing for initial household distribution (4 person-days per village)\n• 1 person-day of training per village\n• PPE for staff: $70 per village\n• Media costs: $100 per village\n• Other transportation and materials costs: $30 per village\nThis amounts to fixed costs of: $302.50 per village for non-mask materials, $347.35 worth of cloth\nmasks per village, and $89.35 of surgical masks per village.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Citizen Services", "scale": "small", "title": "Plain-language service pages and proactive status updates", "idea": "Rewrite high-volume pages and letters into plain language, add status notifications, and measure contact reduction.", "quote": "Support is also available from:\nMedicare Mental Health phone service on 1800 595 212 or visit the Government’s\nMedicare Mental Health\nwebsite to find mental health services and resources\nLifeline\non 13 11 14, text 0477 13 11 14 or access its services online including chat\nKids Helpline\non 1800 55 1800 or access its services online\nBeyond Blue\non 1300 22 4636 or access its services online\nNurse Midwife Health Program Australia\n1800 001060\nDoctors' Health Line 1800 006 888\nthe Transcultural Mental Health Line on 1800 648 911\n13 YARN\n: 13 92 76 – Aboriginal and Torres Strait Islander Crisis Support\nDr4Drs\non 1300 374 377\nThe\nEssential Network (TEN) Black Dog Institute | Better Mental Health\n.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / service users", "source": "pages/announcements-index__04.html (https://www.health.gov.au/news/statement-of-support)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Citizen Services", "scale": "large", "title": "Single front door for life-event based services", "idea": "Bundle services around life events so citizens can complete related steps across agencies in one journey.", "quote": "Support is also available from:\nMedicare Mental Health phone service on 1800 595 212 or visit the Government’s\nMedicare Mental Health\nwebsite to find mental health services and resources\nLifeline\non 13 11 14, text 0477 13 11 14 or access its services online including chat\nKids Helpline\non 1800 55 1800 or access its services online\nBeyond Blue\non 1300 22 4636 or access its services online\nNurse Midwife Health Program Australia\n1800 001060\nDoctors' Health Line 1800 006 888\nthe Transcultural Mental Health Line on 1800 648 911\n13 YARN\n: 13 92 76 – Aboriginal and Torres Strait Islander Crisis Support\nDr4Drs\non 1300 374 377\nThe\nEssential Network (TEN) Black Dog Institute | Better Mental Health\n.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / service users", "source": "pages/announcements-index__04.html (https://www.health.gov.au/news/statement-of-support)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Citizen Participation", "scale": "small", "title": "Consultation feedback summaries with response tracking", "idea": "Summarise consultation submissions by theme and publish what changed in response.", "quote": "3 – Using RAT to detect cases early in high-risk settings\nCohort\nTesting Recommendation\nComment\nResidential aged and disability care settings where there is high community prevalence\nDaily RAT for all staff (minimum twice weekly where supply constraints exist)\nRAT for visitors at each visit\nThis regime is subject to local consideration of community prevalence and availability of RAT.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "pages/announcements-index__17.html (https://www.health.gov.au/news/ahppc-statement-on-rapid-antigen-testing-for-current-high-community-prevalence-environment)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Citizen Participation", "scale": "large", "title": "Always-on policy participation platform", "idea": "Create a standing participation platform where citizens and stakeholders can propose, vote, and track ideas.", "quote": "3 – Using RAT to detect cases early in high-risk settings\nCohort\nTesting Recommendation\nComment\nResidential aged and disability care settings where there is high community prevalence\nDaily RAT for all staff (minimum twice weekly where supply constraints exist)\nRAT for visitors at each visit\nThis regime is subject to local consideration of community prevalence and availability of RAT.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "pages/announcements-index__17.html (https://www.health.gov.au/news/ahppc-statement-on-rapid-antigen-testing-for-current-high-community-prevalence-environment)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Regulation & Policy", "scale": "small", "title": "Regulatory burden scan for forms, guidance, and reporting", "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.", "quote": "For context, [63] estimate that the value of a statistical life is $205,000 in Bangladesh, implying\nthat our intervention at scale is 4-20 times more cost-effective than what the typical Bangladeshi\nwould be willing to pay to reduce mortality risk, and therefore a \"very good buy\" for policymakers.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "category": "Regulation & Policy", "scale": "large", "title": "Adaptive regulation program with live feedback loops", "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.", "quote": "For context, [63] estimate that the value of a statistical life is $205,000 in Bangladesh, implying\nthat our intervention at scale is 4-20 times more cost-effective than what the typical Bangladeshi\nwould be willing to pay to reduce mortality risk, and therefore a \"very good buy\" for policymakers.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf (https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] } ], "legislation_administered": [], "artifacts": [ { "category": "other-pdfs", "year": null, "url": "https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf", "file": "other-pdfs/Mask_RCT____Symptomatic_Seropositivity_083121.pdf", "bytes": 5697936, "link_text": "https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf" } ], "_meta": { "snapshot_built_at": "2026-05-13T11:02:39+00:00", "strategy_brief_meta": { "model": "nova-micro", "folder": "Australian-Health-Protection-Principal-Committee", "annual_report": { "file": null, "url": "", "year": null }, "corporate_plan": { "file": "other-pdfs\\Mask_RCT____Symptomatic_Seropositivity_083121.txt", "url": "https://www.poverty-action.org/sites/default/files/publications/Mask_RCT____Symptomatic_Seropositivity_083121.pdf", "year": null }, "usage": { "input_tokens": 12919, "output_tokens": 155, "total_tokens": 13074, "model": "nova-micro" }, "cost_usd": 0.000473865, "elapsed_seconds": 1.93, "generated_at": "2026-05-13T05:15:39+00:00" }, "ideas_manifest": { "entity_id": "B-002559", "entity_name": "Australian Health Protection Principal Committee", "folder_name": "Australian-Health-Protection-Principal-Committee", "generated_at": "2026-05-09T23:05:36.237028+00:00", "idea_count": 12, "markdown": "ideas/Australian-Health-Protection-Principal-Committee_ideas.md", "jsonl": "ideas/ideas.jsonl", "inputs": [ "Australian-Health-Protection-Principal-Committee_strategy-overview.md", "strategy-evidence.json", "global-intelligence/source-manifest.json" ] }, "global_intel_meta": null } }